Mark Patrick Guerin

Mark Patrick Guerin appears in our data through filings on Traws Pharma, Inc. shares, published by SEC (Form 4). We count 21 filings; the first trade dates from 29 July 2016 and the latest from 18 June 2024.

Purchases make up the whole of the open-market record (6 purchases, €43k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 8 share grants and 7 option exercises.

In size, the median ticket on the buying side is €5,289. On 6 out of 6 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

On 20 June 2024 came the latest disclosure, a share grant for €972 in Traws Pharma, Inc. The most recent open-market purchase was published on 17 February 2021, 2,074 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.